DUXAP8 and hepatocellular carcinoma: As shown, the inhibition of miR‐422a reversed the effect of DUXAP8 knockdown on the proliferation, migration, and invasion of HCC cells; overexpression of miR‐422a attenuated the effect of overexpressing DUXAP8 on proliferation, migration, and invasion of HCC cells (Figure 5B,C).